Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene W M Ng

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Annals of the New York Academy of Sciences|December 6, 2006
Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseasesEugene W M Ng, Anthony P Adamis
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 11, 2005
Targeting angiogenesis, the underlying disorder in neovascular age-related macular degenerationEugene W M Ng, Anthony P Adamis
Retina (Philadelphia, Pa.)|December 12, 2002
Iatrogenic choroidal neovascularization occurring in patients undergoing macular surgeryEugene W M Ng, Neil M Bressler, David S Boyer, et al.
Current Eye Research|January 6, 2004
Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbitEugene W M Ng, Myung-Jin Joo, Kah-Guan Au Eong, et al.
Nature Reviews. Drug Discovery|March 7, 2006
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular diseaseEugene W M Ng, David T Shima, Perry Calias, et al.
Retina (Philadelphia, Pa.)|November 21, 2002
Contribution of pneumolysin and autolysin to the pathogenesis of experimental pneumococcal endophthalmitisEugene W M Ng, J Ricardo Costa, Nasrollah Samiy, et al.
Ophthalmology|October 7, 2004
Macular translocation in patients with recurrent subfoveal choroidal neovascularization after laser photocoagulation for nonsubfoveal choroidal neovascularizationEugene W M Ng, Gildo Y Fujii, Kah-Guan Au Eong, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Annals of the New York Academy of Sciences|December 6, 2006
Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseasesEugene W M Ng, Anthony P Adamis
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 11, 2005
Targeting angiogenesis, the underlying disorder in neovascular age-related macular degenerationEugene W M Ng, Anthony P Adamis
Retina (Philadelphia, Pa.)|December 12, 2002
Iatrogenic choroidal neovascularization occurring in patients undergoing macular surgeryEugene W M Ng, Neil M Bressler, David S Boyer, et al.
Current Eye Research|January 6, 2004
Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbitEugene W M Ng, Myung-Jin Joo, Kah-Guan Au Eong, et al.
Nature Reviews. Drug Discovery|March 7, 2006
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular diseaseEugene W M Ng, David T Shima, Perry Calias, et al.
Retina (Philadelphia, Pa.)|November 21, 2002
Contribution of pneumolysin and autolysin to the pathogenesis of experimental pneumococcal endophthalmitisEugene W M Ng, J Ricardo Costa, Nasrollah Samiy, et al.
Ophthalmology|October 7, 2004
Macular translocation in patients with recurrent subfoveal choroidal neovascularization after laser photocoagulation for nonsubfoveal choroidal neovascularizationEugene W M Ng, Gildo Y Fujii, Kah-Guan Au Eong, et al.
Pageof 1